CN103495113B - Traditional Chinese medicine composition for treating henoch-schonleinpurpura - Google Patents
Traditional Chinese medicine composition for treating henoch-schonleinpurpura Download PDFInfo
- Publication number
- CN103495113B CN103495113B CN201310407928.7A CN201310407928A CN103495113B CN 103495113 B CN103495113 B CN 103495113B CN 201310407928 A CN201310407928 A CN 201310407928A CN 103495113 B CN103495113 B CN 103495113B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine composition
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 62
- 239000000203 mixture Substances 0.000 title claims abstract description 28
- 206010019617 Henoch-Schonlein purpura Diseases 0.000 title claims abstract description 16
- 208000031814 IgA Vasculitis Diseases 0.000 title claims abstract description 16
- 208000015446 immunoglobulin a vasculitis Diseases 0.000 title claims abstract description 16
- 201000004331 Henoch-Schoenlein purpura Diseases 0.000 title abstract 2
- 241000756943 Codonopsis Species 0.000 claims abstract description 10
- 239000009636 Huang Qi Substances 0.000 claims abstract description 10
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 10
- 238000002360 preparation method Methods 0.000 claims abstract description 8
- 239000000463 material Substances 0.000 claims abstract description 6
- 210000000582 semen Anatomy 0.000 claims description 27
- 229940079593 drug Drugs 0.000 claims description 19
- 241000628997 Flos Species 0.000 claims description 18
- 239000006187 pill Substances 0.000 claims description 12
- 241000600871 Euryale <brittle star> Species 0.000 claims description 9
- 235000006487 Euryale ferox Nutrition 0.000 claims description 9
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 7
- 238000009472 formulation Methods 0.000 claims description 5
- 238000007493 shaping process Methods 0.000 claims description 5
- 230000008901 benefit Effects 0.000 abstract description 5
- 241000411851 herbal medicine Species 0.000 abstract description 3
- 230000004069 differentiation Effects 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000605447 Anemarrhena Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 244000247747 Coptis groenlandica Species 0.000 abstract 1
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 244000111489 Gardenia augusta Species 0.000 abstract 1
- 235000018958 Gardenia augusta Nutrition 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 241001071917 Lithospermum Species 0.000 abstract 1
- 241000123069 Ocyurus chrysurus Species 0.000 abstract 1
- 241000208966 Polygala Species 0.000 abstract 1
- 244000292697 Polygonum aviculare Species 0.000 abstract 1
- 235000006386 Polygonum aviculare Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 240000004064 Poterium sanguisorba Species 0.000 abstract 1
- 235000008291 Poterium sanguisorba Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 244000126002 Ziziphus vulgaris Species 0.000 abstract 1
- 229930191283 anemarrhena Natural products 0.000 abstract 1
- 244000022778 quail grass Species 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 27
- 210000004369 blood Anatomy 0.000 description 27
- 206010037549 Purpura Diseases 0.000 description 14
- 241001672981 Purpura Species 0.000 description 14
- 230000000694 effects Effects 0.000 description 14
- 210000000952 spleen Anatomy 0.000 description 14
- 208000032843 Hemorrhage Diseases 0.000 description 12
- 235000009508 confectionery Nutrition 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 11
- 210000003734 kidney Anatomy 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 238000007920 subcutaneous administration Methods 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 230000023597 hemostasis Effects 0.000 description 5
- 231100000252 nontoxic Toxicity 0.000 description 5
- 230000003000 nontoxic effect Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 230000002354 daily effect Effects 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 206010034754 petechiae Diseases 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 206010014080 Ecchymosis Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 231100001252 long-term toxicity Toxicity 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 206010001598 Alcohol intolerance Diseases 0.000 description 1
- 208000032467 Aplastic anaemia Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019705 Hepatic pain Diseases 0.000 description 1
- 208000031953 Hereditary hemorrhagic telangiectasia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021074 Hypoplastic anaemia Diseases 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- HKOIDIVCPUDLBS-UHFFFAOYSA-N Skullcapflavone II Natural products Oc1cccc(O)c1C2=CC(=O)c3c(O)c(O)c(O)c(O)c3O2 HKOIDIVCPUDLBS-UHFFFAOYSA-N 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 206010043561 Thrombocytopenic purpura Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 1
- 229960003321 baicalin Drugs 0.000 description 1
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000001989 choleretic effect Effects 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000001501 megacaryocyte Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- GMQFOKBGMKVUQZ-UHFFFAOYSA-N scullcapflavone II Chemical compound COC1=CC=CC(O)=C1C1=CC(=O)C2=C(O)C(OC)=C(OC)C(OC)=C2O1 GMQFOKBGMKVUQZ-UHFFFAOYSA-N 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 206010043554 thrombocytopenia Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A traditional Chinese medicine composition for treating henoch-schonleinpurpura relates to the technical field of Chinese herbal medicines, and is a medicament prepared from the following raw materials in part by weight: 28-32 parts of coptis, 28-32 parts of cape jasmine, 28-32 parts of radix scutellariae, 33-37 parts of ciliatenerve knotweed root, 18-22 parts of anemarrhena, 28-32 parts of radix astragali, 38-42 parts of Chinese yam, 28-32 parts of poriacocos, 33-37 parts of bighead atractylodes rhizome, 38-42 parts of Chinese angelica, 40-52 parts of raw rehmannia root, 38-42 parts of radix paeoniae alba, 23-27 parts of peach seeds, 23-27 parts of celosia cristata, 23-27 parts of sophora flower, 48-52 parts of euryaleferoxsalisb, 18-22 parts of garden burnet, 28-32 parts of jujube kernel, 28-32 parts of lithospermum, 33-37 parts of madder, 38-42 parts of radix curcumae, 28-32 parts of cortex moutan, 38-42 parts of ligusticumwallichii, 63-67 parts of polygala root and 58-62 parts of radix codonopsis. The traditional Chinese medicine composition is accord with traditional Chinese medicine syndrome differentiation theory on traditional Chinese medicinal material selection and compatibility; and the traditional Chinese medicine composition has the advantages of simple preparation method, fast effectiveness, high cure rate, uneasiness in recurrence and the like.
Description
Technical field
The present invention relates to field of Chinese herbal medicine technology, be specifically related to a kind of Chinese medicine composition being used for the treatment of anaphylactoid purpura.
Background technology
In life, body surface often can find " blue block ", is medically all called purpura, and this is the expression of subcutaneous hemorrhage, thisly hemorrhagely as pinprick, can be called petechia; Also can in a sheet of, this is endovascular blood from overflowing, and it is scarlet for starting color, becomes yellowish-brown remote hemorrhage after 2-3 day.Petechia, purpura and ecchymosis all represent be subcutaneous have hemorrhage, just hemorrhage number and the varying in size, if be called hematoma when subcutaneous hemorrhage significantly swells with skin of hemorrhage scope.The main cause of subcutaneous hemorrhage is that blood vessel wall is impaired, makes blood be exuded to outside blood vessel from Ink vessel transfusing, and the diameter of petechia is at 3-5 millimeter, be called purpura, cause the disease of purpura to have anaphylactoid purpura, sulfonamide causes the common of allergy, and the anaphylactoid purpura after insect bite wound also often has.Old people's blood vessel elasticity goes down, and fragility increases, and colliding lightly will subcutaneous hemorrhage.Young woman often has purpura, does not need treatment to disappear voluntarily, its purpura agnogenio.All can there is subcutaneous hemorrhage in other all factors causing blood vessel wall fragility to increase, as antibacterial or viral infection, malnutrition, hypovitaminosis C and rare hereditary hemorrhagic telangiectasia.Except above-mentioned blood vessel injury factor, with thrombocytopenia or platelet matter difference also relevant.The disease causing platelet quality to change is a lot, as essential thrombocytopenia purpura, also can be hemopoietic Bone MarrowBank in caused by pathological changes, as hypoplastic anemia, leukemia, myeloma.Physical chemical factor destroys makes hematoblastic megalokaryocyte, as lonizing radiation, anticancer chemotherapy etc.
At present, doctor trained in Western medicine, except employing antiallergic, also uses immunosuppressant, and side effect is large, easily recurs.Chinese medicine primary disease is used to have unique science practical value, adopt differentiation of tcm fundamentally can nurse one's health the yin and yang imbalance state of patient, accomplish overall conditioning and personalized medicine, in consolidate curative effect, alleviate toxic and side effects aspect and there is obvious advantage, clinically achieve comparatively satisfied effect.
Summary of the invention
It is high that technical problem to be solved by this invention is to provide a kind of cure rate, the safe and reliable Chinese medicine composition being used for the treatment of anaphylactoid purpura.
Technical problem to be solved by this invention realizes by the following technical solutions:
Be used for the treatment of a Chinese medicine composition for anaphylactoid purpura, the medicament be made up of the crude drug of following weight portion,
Rhizoma Coptidis 28-32 part, Fructus Gardeniae 28-32 part, Radix Scutellariae 28-32 part, Radix Polygoni Ciliinerve 33-37 part, Rhizoma Anemarrhenae 18-22 part, Radix Astragali 28-32 part, Rhizoma Dioscoreae 38-42 part, Poria 28-32 part, Rhizoma Atractylodis Macrocephalae 33-37 part, Radix Angelicae Sinensis 38-42 part, Radix Rehmanniae 40-52 part, Radix Paeoniae Alba 38-42 part, Semen Persicae 23-27 part, Flos Celosiae Cristatae 23-27 part, Flos Sophorae 23-27 part, Semen Euryales 48-52 part, Radix Sanguisorbae 18-22 part, Semen Ziziphi Spinosae 28-32 part, Radix Arnebiae (Radix Lithospermi) 28-32 part, Radix Rubiae 33-37 part, Radix Curcumae 38-42 part, Cortex Moutan 28-32 part, Rhizoma Chuanxiong 38-42 part, Radix Polygalae 63-67 part, Radix Codonopsis 58-62 part.
Preferred weight part of each crude drug is:
Rhizoma Coptidis 30 parts, Fructus Gardeniae 30 parts, Radix Scutellariae 30 parts, Radix Polygoni Ciliinerve 35 parts, the Rhizoma Anemarrhenae 20 parts, the Radix Astragali 30 parts, Rhizoma Dioscoreae 40 parts, 30 parts, Poria, the Rhizoma Atractylodis Macrocephalae 35 parts, Radix Angelicae Sinensis 40 parts, 50 parts, the Radix Rehmanniae, the Radix Paeoniae Alba 40 parts, 25 parts, Semen Persicae, Flos Celosiae Cristatae 25 parts, 25 parts, Flos Sophorae, Semen Euryales 50 parts, Radix Sanguisorbae 20 parts, Semen Ziziphi Spinosae 30 parts, Radix Arnebiae (Radix Lithospermi) 30 parts, 35 parts, Radix Rubiae, Radix Curcumae 40 parts, Cortex Moutan 30 parts, Rhizoma Chuanxiong 40 parts, Radix Polygalae 65 parts, Radix Codonopsis 60 parts.
Crude drug used by the present invention can be bought from common Chinese shop and obtain, and its specification meets national Chinese crude drug standard.
Chinese medicine composition of the present invention can add various adjuvants required when preparing different dosage form, such as disintegrating agent, lubricant, adhesive etc., the conventional oral formulations of any one is prepared into the method for Chinese medicinal of routine, wherein, described oral formulations can be decoction, pill, capsule or tablet.
Another object of the present invention is to provide a kind of method preparing the present composition, comprises the steps,
1) each crude drug is taken by following parts by weight: Rhizoma Coptidis 30 parts, Fructus Gardeniae 30 parts, Radix Scutellariae 30 parts, Radix Polygoni Ciliinerve 35 parts, the Rhizoma Anemarrhenae 20 parts, the Radix Astragali 30 parts, Rhizoma Dioscoreae 40 parts, 30 parts, Poria, the Rhizoma Atractylodis Macrocephalae 35 parts, Radix Angelicae Sinensis 40 parts, 50 parts, the Radix Rehmanniae, the Radix Paeoniae Alba 40 parts, 25 parts, Semen Persicae, Flos Celosiae Cristatae 25 parts, 25 parts, Flos Sophorae, Semen Euryales 50 parts, Radix Sanguisorbae 20 parts, Semen Ziziphi Spinosae 30 parts, Radix Arnebiae (Radix Lithospermi) 30 parts, 35 parts, Radix Rubiae, Radix Curcumae 40 parts, Cortex Moutan 30 parts, Rhizoma Chuanxiong 40 parts, Radix Polygalae 65 parts, Radix Codonopsis 60 parts;
2) above-mentioned each taste material medicine is ground to form mix homogeneously after smalls, then add common carrier, preparations shaping, obtain pill.
1, pharmacology analysis:
Rhizoma Coptidis: heat clearing and damp drying, eliminating fire and detoxication.
Fructus Gardeniae: bitter, cold, nontoxic.Pathogenic fire purging relieving restlessness; Clearing away heat-damp and promoting diuresis; Removing pathogenic heat from blood and toxic substance from the body.
Radix Scutellariae: containing the composition such as baicalin and neobaicalein, antimicrobial spectrum is comparatively wide, has inhibitory action to various bacteria, dermatophytes, leptospira etc.
Radix Polygoni Ciliinerve: bitter in the mouth is micro-puckery, cool in nature.Anti-inflammation, pleasantly invigorates blood circulation, cooling blood for hemostasis, tranquillizing to relieve muscle spasm, pain relieving.
The Rhizoma Anemarrhenae: bitter, sweet, cold.Return lung, stomach, kidney channel.Have resisting pathogenic microbes effect, nicotinic acid contained in the Rhizoma Anemarrhenae, have the effect maintaining skin and neurological health and facilitating digestion road function, the Mengiferin raised from Rhizoma Anemarrhenae leaf has obvious choleretic effect, also can anticoagulant.
The Radix Astragali: nature and flavor are sweet, tepor, return spleen, lung meridian is QI invigorating key medicine.
Rhizoma Dioscoreae: sweet in the mouth, property is put down.Return spleen, lung, kidney channel.There are strengthening the spleen and stomach, tonifying the lung kidney, invigorating the spleen and replenishing QI, spleen invigorating tonify deficiency, the effects such as beneficial essence, beneficial heart and tranquilizing mind of reinforcing the kidney.
Poria: sweet, light is flat.GUIXIN, lung, spleen, kidney channel.Promoting diuresis to eliminate damp pathogen, strengthening the spleen stomach function regulating, spleen invigorating mind calming.
The Rhizoma Atractylodis Macrocephalae: warm in nature, bitter in the mouth, sweet.Invigorating the spleen and benefiting QI, dampness diuretic.
Radix Angelicae Sinensis: " book on Chinese herbal medicine just ": Radix Angelicae Sinensis, its sweet in the mouth and weighing, therefore specially can enrich blood, its gas is light and pungent, therefore again can promoting the circulation of blood, and invigorating middle warmer has, and have benefit, the gas medicine in sincere blood in row, the panacea also in blood also.
The Radix Rehmanniae: cold in nature, function is heat clearing and blood cooling, enriching yin and nourishing kidney, promoting the production of body fluid to quench thirst.
The Radix Paeoniae Alba: cool in nature, bitter in the mouth acid, is slightly cold, has easing the affected liver of enriching blood, suppressing the hyperactive liver pain relieving.Paeoniflorin has antibacterial, antipyretic, antiinflammatory, increase coronary flow, improves the effect of myocardial nutritional flow, blood vessel dilating.
Semen Persicae: bitter but sweet flavor and property are put down, and can enter the heart, liver, large intestine, blood circulation promoting and blood stasis dispelling effect is very wide, availablely controls the various worn-out disease of stagnation of blood stasis.
Flos Celosiae Cristatae: sweet, puckery, cool.Return liver, large intestine channel.There is cooling blood for hemostasis, yin nourishing invigorating the liver and kidney, the merit of relieving heat toxin.
Flos Sophorae: bitter in the mouth, cold nature, returns liver, large intestine channel; Enter blood to hold back and fall, body slightly falls apart; There is cooling blood for hemostasis, effect of purging liver-fire.
Semen Euryales: sweet in the mouth, puckery, property is put down, nontoxic.Invigorating the spleen and replenishing QI, strong will of refreshing oneself.
Radix Sanguisorbae: picric acid; Cold; Nontoxic.Cooling blood for hemostasis, heat-clearing and toxic substances removing, detumescence sore.
Semen Ziziphi Spinosae: sweet in the mouth, acid, property is put down.Can conscience be nourished, calm the nerves, arresting sweating.
Radix Arnebiae (Radix Lithospermi): cold in nature is sweet in the mouth, salty.Cure mainly removing heat from blood, invigorate blood circulation, removing toxic substances rash.Contain for heat in blood poison, macule purple is black, measles without adequate eruption, skin infection, eczema, burn due to hot liquid or fire.
Radix Rubiae: cold in nature, bitter in the mouth, enters the heart, Liver Channel, has effect of promoting the circulation of blood hemostasis, dredge the meridian passage, eliminating phlegm and stopping cough.
Radix Curcumae: pungent, bitter, cold.Return liver, the heart, lung meridian.Promoting blood circulation and stopping pain, promoting QI circulation for relieving depression, clear away heart-fire removing heat from blood, promoting the function of the gallbladder to alleviate jaundice.
Cortex Moutan: bitter in the mouth, pungent, is slightly cold.GUIXIN, liver, kidney channel.Clearing away heat and cooling blood; Promoting blood circulation to remove blood stasis.
Rhizoma Chuanxiong: acrid in the mouth, warm in nature.Return liver, gallbladder, pericardium channel.Blood-activating and qi-promoting, wind-expelling pain-stopping.
Radix Polygalae: bitter, pungent, tepor.GUIXIN, kidney, lung meridian.Taste bitter in taste acting on the heart, temperature promoting the circulation of blood, and fragrance is cool, can pass through again edema caused by disorder of QI.
Radix Codonopsis: there is invigorating the spleen and replenishing QI, effect of spleen invigorating lung benefiting.
2, usage and consumption:
The dosage of medicine of the present invention depends on concrete dosage form, and the factor such as the age of patient, body weight, health status.Instruction: pill, gets an auxiliary medicine, is prepared into pill, every ball 3-5g, daily 2-3 ball, about 10g, within 7 days, is 1 course for the treatment of.
The traditional Chinese medical science is thought, primary disease is many because of bleeding due to blood-heat, and forcing blood is excessive in passages through which vital energy circulates, and channels forms purpura.Patients on long-term is insufficiency of the spleen, sinking of QI of middle-JIAO, failure of the spleen to keep the blood flowing within the vessels, makes blood oozing from the body openings or subcuta neous tissue in meridians.Therefore this prescription mainly based on QI invigorating, invigorate blood circulation, reach therapeutic purposes.
3, the present composition has carried out a large amount of clinical trials of a large amount of animal acute toxicity tests, long-term toxicity test for animals and disease therapy, drops into the use link of disease therapy provide science and objective foundation to this medicine.Its test method and result of the test are distinguished as follows:
1) animal acute toxicity test is carried out to pill prepared by the present invention:
Medicine: the crude drug used by the present invention is bought from common Chinese shop and obtained, and its specification meets national Chinese crude drug standard.
Experimental animal: mice, body weight is at about 50g, and male and female Stochastic choice, is bought by market.
Method and result: get mice 50, hungry 20 hours, by every every day medicine feed ball 6 ball, feed one week continuously, observe 10 days, mice is movable normal, non-toxic reaction, nothing death.Show that oral liquid is without acute toxicity, clinical medicine dose safety.
2) long-term toxicity test for animals is carried out to pill prepared by the present invention:
Experimental animal: rat, body weight is at 120-130g, and male and female Stochastic choice, is bought by market.
Method and result: get rat 20, be divided into 2 groups, often organize 10, wherein the 1st group as administration group, by every every day medicine feed ball 4 ball, 2nd group of diet as a control group, once a day, continuous irrigation is fed 90 days, survey body weight, 24 hours sacrificed by decapitation after last administration, survey blood, routine urinalysis, liver function, renal function, core, the internal organs such as kidney, the change of tissues observed form, observe the effect of dosage, observe diet, movable change, experiment proves that administration group compares without significant change with matched group, equal non-toxic reaction, a kind of safe drugs.
4, diagnostic criteria
1) clinical diagnosis: have allergic constitution or have the anaphylactogen comparatively affirmed to cause; Whole body or the visible point-like of extremity or speckle shape hemorrhage, recurrent exerbation; Or hemorrhage speckle slightly exceeds skin, color is scarlet or dark red, micro-ly itches, and can accompany the diseases such as stomachache or joint aches; Can be there is headache in severe patient, stupor, has blood in stool, hematuria.
2) in order to verify clinical efficacy, this prescription is tried out in Jieshou City, Anhui First People's Hospital respectively, and random selecting is 50 routine patients wherein.
3) Therapeutic Method: according to drug ratios of the present invention, takes raw material (dose), obtains pill according to usual formulation method, every day 2 ball, sooner or later service once, taking 7 days is a course for the treatment of, the shortest 2 courses for the treatment of, the longest 6 courses for the treatment of.
4) efficacy determination:
Recovery from illness: purpura is all disappeared, and gastrointestinal symptom disappears completely, arthralgia disappears; Effective: purpura major part disappears, gastrointestinal symptom basic controlling, and arthralgia takes a turn for the better; Invalid: to treat rear symptom, sign compared with before treatment without any change; Concrete therapeutic outcome is see table 1.
Table 1
| Number of cases | Recovery from illness | Effectively | Invalid | Effective percentage (%) |
| 50 | 33 | 15 | 2 | 96 |
5, points for attention:
1. diet should be light, gives up alcohol and pungent, raw and cold, greasy food.
2. child, women breast-feeding their children, elderly and infirm should take under doctor instructs.
3. driver, work high above the ground person are cautious use of.
4. strictly take by usage and dosage, this medicine should not be taken for a long time in a large number.
5. pair this medicine and alcohol intolerance person forbidding, allergic constitution person be cautious use of.
6. prohibit the use when this property of drug changes.
7. please this medicine is placed on the place that child can not contact.
8. as used other medicines, please Ref Dr or pharmacist before using this medicine.
The invention has the beneficial effects as follows: the present invention selects at Chinese crude drug and compatibility meets Chinese medical discrimination theory, and compound method simply, and have rapid-action, cure rate is high, not easily the advantage such as recurrence.
Detailed description of the invention
The technological means realized to make the present invention, creation characteristic, reaching object and effect is easy to understand, below in conjunction with specific embodiment, setting forth the present invention further.
Embodiment 1
Take each crude drug: Rhizoma Coptidis 30g, Fructus Gardeniae 30g, Radix Scutellariae 30g, Radix Polygoni Ciliinerve 35g, Rhizoma Anemarrhenae 20g, Radix Astragali 30g, Rhizoma Dioscoreae 40g, Poria 30g, Rhizoma Atractylodis Macrocephalae 35g, Radix Angelicae Sinensis 40g, Radix Rehmanniae 50g, Radix Paeoniae Alba 40g, Semen Persicae 25g, Flos Celosiae Cristatae 25g, Flos Sophorae 25g, Semen Euryales 50g, Radix Sanguisorbae 20g, Semen Ziziphi Spinosae 30g, Radix Arnebiae (Radix Lithospermi) 30g, Radix Rubiae 35g, Radix Curcumae 40g, Cortex Moutan 30g, Rhizoma Chuanxiong 40g, Radix Polygalae 65g, Radix Codonopsis 60g.Above-mentioned each taste material medicine is ground to form mix homogeneously after smalls, then add common carrier, preparations shaping, obtain pill.Every ball 3-5g, daily 2-3 ball, about 10g 7 days was 1 course for the treatment of.
Embodiment 2
Each crude drug is taken: Rhizoma Coptidis 28g, Fructus Gardeniae 28g, Radix Scutellariae 28g, Radix Polygoni Ciliinerve 33g, Rhizoma Anemarrhenae 18g, Radix Astragali 28g, Rhizoma Dioscoreae 38g, Poria 28g, Rhizoma Atractylodis Macrocephalae 33g, Radix Angelicae Sinensis 38g, Radix Rehmanniae 40g, Radix Paeoniae Alba 38g, Semen Persicae 23g, Flos Celosiae Cristatae 23g, Flos Sophorae 23g, Semen Euryales 48g, Radix Sanguisorbae 18g, Semen Ziziphi Spinosae 28g, Radix Arnebiae (Radix Lithospermi) 28g, Radix Rubiae 33g, Radix Curcumae 38g, Cortex Moutan 28g, Rhizoma Chuanxiong 38g, Radix Polygalae 63g, Radix Codonopsis 58g by following parts by weight.Above-mentioned each taste material medicine is ground to form mix homogeneously after smalls, then add common carrier, preparations shaping, obtain pill.Every ball 3-5g, daily 2-3 ball, about 10g 7 days was 1 course for the treatment of.
Embodiment 3
Each crude drug is taken: Rhizoma Coptidis 32g, Fructus Gardeniae 32g, Radix Scutellariae 32g, Radix Polygoni Ciliinerve 37g, Rhizoma Anemarrhenae 22g, Radix Astragali 32g, Rhizoma Dioscoreae 42g, Poria 32g, Rhizoma Atractylodis Macrocephalae 37g, Radix Angelicae Sinensis 42g, Radix Rehmanniae 52g, Radix Paeoniae Alba 42g, Semen Persicae 27g, Flos Celosiae Cristatae 27g, Flos Sophorae 27g, Semen Euryales 52g, Radix Sanguisorbae 22g, Semen Ziziphi Spinosae 32g, Radix Arnebiae (Radix Lithospermi) 32g, Radix Rubiae 37g, Radix Curcumae 42g, Cortex Moutan 32g, Rhizoma Chuanxiong 42g, Radix Polygalae 67g, Radix Codonopsis 62g by following parts by weight.Above-mentioned each taste material medicine is ground to form mix homogeneously after smalls, then add common carrier, preparations shaping, obtain pill.Every ball 3-5g, daily 2-3 ball, about 10g 7 days was 1 course for the treatment of.
Model case:
Case 1
Lee, man, 22 years old, student, people from Jieshou City, Anhui Province.In June, 2011 goes to a doctor, sudden tormina.On inspection, find two lower limb large area purpura, not fading of purpura pressure, red tongue, rapid pulse and strong, be diagnosed as anaphylactoid purpura.Take prescription of the present invention, 2 the courses for the treatment of purpura disappear, symptom turns for the better by and large, after take again 3 courses for the treatment of continuously, follow up a case by regular visits to 1 year, do not recur.
Case 2
Lee so-and-so, man, 38 years old, civil servant, people from Jieshou City, Anhui Province.After once drinking, there is purpura in arm, for a long time not under, by being diagnosed as anaphylactoid purpura.Take prescribed treatment of the present invention, 1 course for the treatment of, the state of an illness is clearly better.For thorough healing, take medicine again 5 courses for the treatment of, recover, follow up a case by regular visits to 1 year, also do not recur after drinking.
Case 3
Xu so-and-so, female, 16 years old, student, people from Jieshou City, Anhui Province.Remaining the bimester of trouble anaphylactoid purpura, mainly there is petechia in patient, even have large stretch of ecchymosis on arm, has a surplus February, have no improvement in hospitalize.After patient takes 2 courses for the treatment of of Chinese medicine of the present invention, purpura point disappears, and symptom is clearly better, after take again 3 courses for the treatment of continuously and consolidated, follow up a case by regular visits to so far, have no recurrence.
More than show and describe ultimate principle of the present invention and principal character and advantage of the present invention.The technical staff of the industry should understand; the present invention is not restricted to the described embodiments; what describe in above-described embodiment and description just illustrates principle of the present invention; without departing from the spirit and scope of the present invention; the present invention also has various changes and modifications, and these changes and improvements all fall in the claimed scope of the invention.Application claims protection domain is defined by appending claims and equivalent thereof.
Claims (6)
1. one kind is used for the treatment of the Chinese medicine composition of anaphylactoid purpura, it is characterized in that, the medicament be made up of the crude drug of following weight portion: Rhizoma Coptidis 28-32 part, Fructus Gardeniae 28-32 part, Radix Scutellariae 28-32 part, Radix Polygoni Ciliinerve 33-37 part, Rhizoma Anemarrhenae 18-22 part, Radix Astragali 28-32 part, Rhizoma Dioscoreae 38-42 part, Poria 28-32 part, Rhizoma Atractylodis Macrocephalae 33-37 part, Radix Angelicae Sinensis 38-42 part, Radix Rehmanniae 40-52 part, Radix Paeoniae Alba 38-42 part, Semen Persicae 23-27 part, Flos Celosiae Cristatae 23-27 part, Flos Sophorae 23-27 part, Semen Euryales 48-52 part, Radix Sanguisorbae 18-22 part, Semen Ziziphi Spinosae 28-32 part, Radix Arnebiae (Radix Lithospermi) 28-32 part, Radix Rubiae 33-37 part, Radix Curcumae 38-42 part, Cortex Moutan 28-32 part, Rhizoma Chuanxiong 38-42 part, Radix Polygalae 63-67 part, Radix Codonopsis 58-62 part.
2. a kind of Chinese medicine composition being used for the treatment of anaphylactoid purpura according to claim 1, it is characterized in that, the medicament be made up of the crude drug of following weight portion: Rhizoma Coptidis 30 parts, Fructus Gardeniae 30 parts, Radix Scutellariae 30 parts, Radix Polygoni Ciliinerve 35 parts, the Rhizoma Anemarrhenae 20 parts, the Radix Astragali 30 parts, Rhizoma Dioscoreae 40 parts, 30 parts, Poria, the Rhizoma Atractylodis Macrocephalae 35 parts, Radix Angelicae Sinensis 40 parts, 50 parts, the Radix Rehmanniae, the Radix Paeoniae Alba 40 parts, 25 parts, Semen Persicae, Flos Celosiae Cristatae 25 parts, 25 parts, Flos Sophorae, Semen Euryales 50 parts, Radix Sanguisorbae 20 parts, Semen Ziziphi Spinosae 30 parts, Radix Arnebiae (Radix Lithospermi) 30 parts, 35 parts, Radix Rubiae, Radix Curcumae 40 parts, Cortex Moutan 30 parts, Rhizoma Chuanxiong 40 parts, Radix Polygalae 65 parts, Radix Codonopsis 60 parts.
3. a kind of Chinese medicine composition being used for the treatment of anaphylactoid purpura according to claim 1 and 2, is characterized in that: described medicament is the preparation that any one is suitable for clinically.
4. a kind of Chinese medicine composition being used for the treatment of anaphylactoid purpura according to claim 3, is characterized in that: described preparation is oral formulations.
5. a kind of Chinese medicine composition being used for the treatment of anaphylactoid purpura according to claim 4, is characterized in that: described oral formulations is pill.
6. prepare a method for Chinese medicine composition described in any one of claim 1 or 2, it is characterized in that: comprise the following steps,
A. each taste crude drug is taken by weight portion described in prescription;
B. above-mentioned each taste material medicine is ground to form mix homogeneously after smalls, then add common carrier, preparations shaping, obtain pill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310407928.7A CN103495113B (en) | 2013-09-09 | 2013-09-09 | Traditional Chinese medicine composition for treating henoch-schonleinpurpura |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310407928.7A CN103495113B (en) | 2013-09-09 | 2013-09-09 | Traditional Chinese medicine composition for treating henoch-schonleinpurpura |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103495113A CN103495113A (en) | 2014-01-08 |
| CN103495113B true CN103495113B (en) | 2015-04-22 |
Family
ID=49860434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310407928.7A Active CN103495113B (en) | 2013-09-09 | 2013-09-09 | Traditional Chinese medicine composition for treating henoch-schonleinpurpura |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103495113B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104707029B (en) * | 2015-03-31 | 2018-05-22 | 山东省立医院 | A kind of Chinese medicine for treating psoriasis |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101095856A (en) * | 2007-07-05 | 2008-01-02 | 北京艺信堂医药研究所 | Chinese traditional medicine for treating anaphylactoid purpura nephritis |
| CN101396531A (en) * | 2008-10-09 | 2009-04-01 | 刘运波 | Traditional Chinese medicine for treating anaphylactoid purpura |
-
2013
- 2013-09-09 CN CN201310407928.7A patent/CN103495113B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101095856A (en) * | 2007-07-05 | 2008-01-02 | 北京艺信堂医药研究所 | Chinese traditional medicine for treating anaphylactoid purpura nephritis |
| CN101396531A (en) * | 2008-10-09 | 2009-04-01 | 刘运波 | Traditional Chinese medicine for treating anaphylactoid purpura |
Non-Patent Citations (4)
| Title |
|---|
| 儿童过敏性紫癜证治与护理述要;赵昕等;《实用中医内科杂志》;20070831;第21卷(第04期);11-12 * |
| 对药治疗过敏性紫癜的用药体会;刘晨帆等;《中医研究》;20050131;第18卷(第01期);51-53 * |
| 小儿过敏性紫癜中医辨治八法;余小红;《湖北中医杂志》;20081231;第30卷(第05期);48-49 * |
| 马秀英,洪尚华.中西医结合治疗过敏性紫癜疗效观察.《山西中医》.1996,第12卷(第02期),19-20. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103495113A (en) | 2014-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103705897A (en) | Cancer pain-relieving plaster | |
| CN101961464A (en) | Chinese medicinal composition for treating jaundice and preparation method thereof | |
| CN101249235B (en) | Chinese medicine for curing esophagus cancer and method of preparing the same | |
| CN102580000B (en) | Medicament for curing cancer pain and preparation method thereof | |
| CN104288644A (en) | Pharmaceutical composition for treating spleen deficiency and preparation method thereof | |
| CN103585478B (en) | Chinese medicinal composition for treating hypertension | |
| CN103920034A (en) | Traditional Chinese medicine composition for alleviating side effects of chemotherapy of cancer patient and preparation method traditional Chinese medicine composition | |
| CN103599474B (en) | A kind of Chinese medicine composition being used for the treatment of poor sleeping quality | |
| CN103494962B (en) | Traditional Chinese medicine composition capable of clearing heat and detoxifying | |
| CN103599238B (en) | A kind of Chinese medicine composition being used for the treatment of seborrheic alopecia | |
| CN103495113B (en) | Traditional Chinese medicine composition for treating henoch-schonleinpurpura | |
| CN103599473B (en) | Traditional Chinese medicinal composition for treating dizziness and chest distress | |
| CN104173913A (en) | Traditional Chinese medicine for treating chronic cholecystitis | |
| CN103908495B (en) | Improve Chinese medicine composition and the method for making of tumor patient Postoperative Immunity function | |
| CN115845009B (en) | Navel moxibustion medicinal powder for treating spleen deficiency diarrhea and application thereof | |
| CN103495016B (en) | Traditional Chinese medicine composition for treating vexation and insomnia | |
| CN103599279B (en) | Traditional Chinese medicinal preparation for treating diabetes | |
| CN105056008A (en) | Traditional Chinese medicine preparation for treating gastrectasia and dyspepsia | |
| CN104922595A (en) | Traditional Chinese medicinal preparation for herpes zoster and preparation method thereof | |
| CN104474467A (en) | Traditional Chinese medicine composition for treating Qi-stagnation and blood stasis type dysmenorrheal and preparation method of traditional Chinese medicine composition | |
| CN105412599A (en) | Preparation tablet capable of resisting chemical therapy side effects and strengthening spleen and stomach | |
| CN104383157B (en) | Pharmaceutical composition for treating simple hidrosis of children | |
| CN103494890A (en) | Traditional Chinese medicine composition for treating vertigo | |
| CN102716294A (en) | Traditional Chinese medicine powder for treating gynaecological dysmenorrhea | |
| CN114177243A (en) | Traditional Chinese medicine composition for preventing and adjuvant therapy of liver tumor and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20181227 Address after: 225300 Pearl River Road, Yongan Town, Taizhou, Jiangsu Province, 108 Patentee after: Wang Yajun Address before: 236508 5 Xu Si administrative village, Guang Wu Town, Jieshou City, Fuyang, Anhui Patentee before: Xu Ruyang |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20190122 Address after: No. 27, 370 Lane, Xinde Road, Pudong New Area, Shanghai, 200120, No. 43-49, 4629 Lane, Chuansha Road, Shanghai (single) Patentee after: SHANGHAI CHUANSHA TIANSHI CLINIC Address before: 225300 Pearl River Road, Yongan Town, Taizhou, Jiangsu Province, 108 Patentee before: Wang Yajun |